Company Registration No. 10227499 (England and Wales)
U.K. Medical Development Associates
Unaudited accounts
for the year ended 30 June 2026
U.K. Medical Development Associates
Unaudited accounts
Contents
U.K. Medical Development Associates
Company Information
for the year ended 30 June 2026
Directors
Mr Jiqing Yang
Dr. Wei Juan Zhang
Company Number
10227499 (England and Wales)
Registered Office
81 Nonsuch Walk
Cheam
Surrey
SM2 7LF
Accountants
Blythe & Co
41 Oldfields Road
Sutton
Surrey
SM1 2NB
U.K. Medical Development Associates
Statement of financial position
as at 30 June 2026
Tangible assets
1,429
2,047
Cash at bank and in hand
233,611
18,182
Creditors: amounts falling due within one year
(242,313)
(6,942)
Net current assets
99,117
68,460
Profit and loss account
100,546
70,507
Members' funds
100,546
70,507
For the year ending 30 June 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 11 August 2026 and were signed on its behalf by
Mr Jiqing Yang
Director
Company Registration No. 10227499
U.K. Medical Development Associates
Notes to the Accounts
for the year ended 30 June 2026
U.K. Medical Development Associates is a private company, limited by guarantee, registered in England and Wales, registration number 10227499. The registered office is 81 Nonsuch Walk, Cheam, Surrey, SM2 7LF.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
4 Years
4
Tangible fixed assets
Computer equipment
Amounts falling due within one year
Other debtors
107,819
57,220
U.K. Medical Development Associates
Notes to the Accounts
for the year ended 30 June 2026
6
Creditors: amounts falling due within one year
2026
2025
Taxes and social security
5,940
6,142
7
Company limited by guarantee
The company is limited by guarantee and has no share capital.
Every member of the company undertakes to contribute to the assets of the company, in the event of a winding up, such an amount as may be required not exceeding £1.
8
Average number of employees
During the year the average number of employees was 0 (2025: 0).